Registering a CAGR of 7.5% over the forecast period, the market value of Hyperimmune Globulins is expected to reach US$ 2290.7 million in the year 2027.
Hyperimmune globulins are immune globulin solutions that are high in antibodies and provide protection against specific diseases by providing passive immunity. Passive immunity is achieved through the administration of purified antibodies that provide immediate and short-term protection against the disease.
The global increase in deadly disease outbreaks is driving the market growth. Hyperimmune globulins are typically used to treat active infections in immunocompromised individuals. Hyperimmune globulins (HIGs) are similar to IVIGs (intravenous immunoglobulins), but they are made from plasma from donors who have high antibody titers against a specific antigen or organism. These donors were either naturally infected or previously exposed to the disease, or they were artificially immunized.
Human hyperimmune globulins are desirable, but donor screening protocols are expensive, and the risk of transmitting unidentified pathogens prevents the widespread use of human immune plasma products. In some cases, these solutions may have serious side effects, which may lead to industry growth.
The report aspects discussed the profile of the top manufacturers of the global Hyperimmune Globulins market. These aspects include the financial status of major companies, trending advancements, and the entire market scenario. Growth of the report has examined Hyperimmune Globulins Market production, demand and growth potential, geographic analysis, as well as current market developments in various regions and countries.
The global Hyperimmune Globulins include the identification and analysis of the various market participants competing in the global market. Prominent competitors include CSL Behring, Grifols (BME: GRF), Biotest (ETR: BIO), Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG, Hualan Bio, Shanghai RAAS, Sichuan Yuanda Shuyang, ADMA Biologics (NASDAQ: ADMA) and others.
Grifols Announces Formal Collaboration with US Government to Develop the First COVID-19-Specific Treatment
March 25, 2020 – Grifols has announced a formal collaboration with the United States Biomedical Advanced Research Development Authority (BARDA), the Food and Drug Administration (FDA), and other Federal public health agencies to collect plasma from convalescent COVID-19 patients, process this plasma into a hyperimmune globulin, and support the necessary preclinical and clinical studies to determine whether anti-SARS-CoV-2 hyperimmune globulin therapy can be successful.
The market is segmented based on the type, applications, companies, and regions.
By Type, it is segmented into
By Application, it is segmented into
During the forecast period, Europe is expected to claim a massive revenue share, retaining its dominant position in the global hyperimmune globulin market. It is important to note that, while a variety of factors contribute to this coveted position, some of the most prominent ones are the rapidly aging population and the presence of advanced healthcare infrastructure.
The Hyperimmune Globulins Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type, and segment. It focuses extensively on revealing a detailed regional analysis. The Global Hyperimmune Globulins Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
Scope of the Report covers Hyperimmune Globulins Market with a detailed analysis of the overall scenario for the market. It also highlights the business participants’ environment in the global marketplace. This report also provides an overview of leading companies covering the latest successful marketing strategies, market contributions, current and historical background, and latest market happenings to help key organizations to grow and generate larger profits. Business players will greatly benefit from this Hyperimmune Globulins Market analysis report as it has vital details to provide about regional markets and expected opportunities for the prediction time period 2022-2027. Growth between segments is used to understand the different growth factors that are expected to dominate the market as a whole and to develop strategies to differentiate between key applications and target markets. It further reveals how the worldwide market is working through efficient information graphics.
Report Attributes | Report Details |
Report Title | Hyperimmune Globulins Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions, and By Key Players: Grifols (BME: GRF), Biotest (ETR: BIO), ADMA Biologics (NASDAQ: ADMA) |
Forecast Period 2022 to 2027 CAGR | CAGR of 7.5% over the forecast period (2022-2027) |
By Type |
|
By Application |
|
By Companies | CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG, Hualan Bio, Shanghai RAAS, Sichuan Yuanda Shuyang, ADMA Biologics |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 140 |
Customization Available | Yes, the report can be customized as per your needs |
What is the study period of this market?
The Hyperimmune Globulins Market is studied from 2017 - 2027.
What is the growth rate of the Hyperimmune Globulins Market?
The Hyperimmune Globulins Market is growing at a CAGR of 7.5% over the next 5 years.
Who are the key players in Hyperimmune Globulins Market?
CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG, Hualan Bio, Shanghai RAAS, Sichuan Yuanda Shuyang, ADMA Biologics
What regions does this Hyperimmune Globulins Market report cover?
North America (the United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
What are the significant types of Hyperimmune Globulins Market?
Hepatitis B Immunoglobulins, Rabies Immunoglobulins, Tetanus Immunoglobulins, Rho(D) Immunoglobulins, Other
What are the major end-use applications of Hyperimmune Globulins Market?
Government Institutions, Private Sector, Other
All our reports are custom made to your company’s needs to a certain extent, we do provide 5 free consulting hours along with the purchase of each report, and this will allow you to request any additional data to customize the report to your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.